# Movado Group Inc: financial statements, quarterly

MOV · NYSE · CIK 72573 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/mov.md) · [Financials](/companies/mov/financials.md) · [Filings](/companies/mov/filings.md) · [Insiders](/companies/mov/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mov/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [184](/filings/0000950170-25-054522.md) | [176](/filings/0000950170-25-054522.md) | [134](/filings/0000950170-25-078622.md) | [157](/filings/0001193125-25-190723.md) | [181](/filings/0001193125-25-294766.md) | [181](/filings/0000950170-25-054522.md) | [132](/filings/0001193125-26-240712.md) | [162](/filings/0001193125-26-366101.md) | [186](/filings/0001193125-25-294766.md) | [192 d](/filings/0001193125-26-115298.md) | [142](/filings/0001193125-26-240712.md) | [170](/filings/0001193125-26-366101.md) |
| Cost of revenue | $m | [84.3](/filings/0000950170-25-054522.md) | [81.7](/filings/0000950170-25-054522.md) | [61.5](/filings/0000950170-25-078622.md) | [71.7](/filings/0001193125-25-190723.md) | [83.9](/filings/0001193125-25-294766.md) | [83.1 d](/filings/0001193125-26-115298.md) | [60.4](/filings/0001193125-26-240712.md) | [74.3](/filings/0001193125-26-366101.md) | [85.1](/filings/0001193125-25-294766.md) | [87.9 d](/filings/0001193125-26-115298.md) | [60.8](/filings/0001193125-26-240712.md) | [68.9](/filings/0001193125-26-366101.md) |
| Gross profit | $m | [99.8](/filings/0000950170-25-054522.md) | [94.1](/filings/0000950170-25-054522.md) | [72.9](/filings/0000950170-25-078622.md) | [85.3](/filings/0001193125-25-190723.md) | [96.6](/filings/0001193125-25-294766.md) | [98.3](/filings/0000950170-25-054522.md) | [71.4](/filings/0001193125-26-240712.md) | [87.6](/filings/0001193125-26-366101.md) | [101](/filings/0001193125-25-294766.md) | [104 d](/filings/0001193125-26-115298.md) | [81.6](/filings/0001193125-26-240712.md) | [101](/filings/0001193125-26-366101.md) |
| Selling, general and administrative | $m | [81.6](/filings/0000950170-25-054522.md) | [83.3](/filings/0000950170-25-054522.md) | [70.8](/filings/0000950170-25-078622.md) | [82.6](/filings/0001193125-25-190723.md) | [90.6](/filings/0001193125-25-294766.md) | [89.1 d](/filings/0001193125-26-115298.md) | [71.1](/filings/0001193125-26-240712.md) | [83.6](/filings/0001193125-26-366101.md) | [89.3](/filings/0001193125-25-294766.md) | [89.8 d](/filings/0001193125-26-115298.md) | [74.6](/filings/0001193125-26-240712.md) | [85.9](/filings/0001193125-26-366101.md) |
| Operating income | $m | [18.2](/filings/0000950170-25-054522.md) | [10.8](/filings/0000950170-25-054522.md) | [2.1](/filings/0000950170-25-078622.md) | [2.6](/filings/0001193125-25-190723.md) | [6.0](/filings/0001193125-25-294766.md) | [9.2](/filings/0000950170-25-054522.md) | [0.3](/filings/0001193125-26-240712.md) | [4.0](/filings/0001193125-26-366101.md) | [11.7](/filings/0001193125-25-294766.md) | [13.8 d](/filings/0001193125-26-115298.md) | [7.0](/filings/0001193125-26-240712.md) | [14.9](/filings/0001193125-26-366101.md) |
| Interest expense | $m | [0.1](/filings/0000950170-25-054522.md) | [0.1](/filings/0000950170-25-054522.md) | [0.1](/filings/0000950170-25-078622.md) | [0.1](/filings/0001193125-25-190723.md) | [0.1](/filings/0001193125-25-294766.md) | [0.1 d](/filings/0001193125-26-115298.md) | [0.1](/filings/0001193125-26-240712.md) | [0.1](/filings/0001193125-26-366101.md) | [0.1](/filings/0001193125-25-294766.md) | [0.2 d](/filings/0001193125-26-115298.md) | [0.1](/filings/0001193125-26-240712.md) | [0.1](/filings/0001193125-26-366101.md) |
| Income tax | $m | [4.2](/filings/0000950170-25-054522.md) | [2.3](/filings/0000950170-25-054522.md) | [2.0](/filings/0000950170-25-078622.md) | [0.8](/filings/0001193125-25-190723.md) | [2.4](/filings/0001193125-25-294766.md) | [2.2 d](/filings/0001193125-26-115298.md) | [0.7](/filings/0001193125-26-240712.md) | [2.0](/filings/0001193125-26-366101.md) | [3.3](/filings/0001193125-25-294766.md) | [1.6 d](/filings/0001193125-26-115298.md) | [1.9](/filings/0001193125-26-240712.md) | [3.5](/filings/0001193125-26-366101.md) |
| Net income | $m | [15.2](/filings/0000950170-25-054522.md) | [9.8](/filings/0000950170-25-054522.md) | [2.0](/filings/0000950170-25-078622.md) | [3.5](/filings/0001193125-25-190723.md) | [4.8](/filings/0001193125-25-294766.md) | [8.1](/filings/0000950170-25-054522.md) | [1.4](/filings/0001193125-26-240712.md) | [3.0](/filings/0001193125-26-366101.md) | [9.6](/filings/0001193125-25-294766.md) | [12.6 d](/filings/0001193125-26-115298.md) | [6.9](/filings/0001193125-26-240712.md) | [12.3](/filings/0001193125-26-366101.md) |
| Diluted EPS | $ per share | [0.67](/filings/0000950170-25-054522.md) | [0.43](/filings/0000950170-25-054522.md) | [0.09](/filings/0000950170-25-078622.md) | [0.15](/filings/0001193125-25-190723.md) | [0.21](/filings/0001193125-25-294766.md) | [0.36](/filings/0000950170-25-054522.md) | [0.06](/filings/0001193125-26-240712.md) | [0.13](/filings/0001193125-26-366101.md) | [0.42](/filings/0001193125-25-294766.md) | not reported | [0.30](/filings/0001193125-26-240712.md) | [0.53](/filings/0001193125-26-366101.md) |
| Basic EPS | $ per share | [0.69](/filings/0000950170-25-054522.md) | [0.44](/filings/0000950170-25-054522.md) | [0.09](/filings/0000950170-25-078622.md) | [0.16](/filings/0001193125-25-190723.md) | [0.22](/filings/0001193125-25-294766.md) | [0.36](/filings/0000950170-25-054522.md) | [0.06](/filings/0001193125-26-240712.md) | [0.13](/filings/0001193125-26-366101.md) | [0.43](/filings/0001193125-25-294766.md) | not reported | [0.31](/filings/0001193125-26-240712.md) | [0.55](/filings/0001193125-26-366101.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [201](/filings/0000950170-25-054522.md) | [262](/filings/0001193125-26-115298.md) | [225](/filings/0000950170-25-078622.md) | [198](/filings/0001193125-25-190723.md) | [182](/filings/0001193125-25-294766.md) | [209](/filings/0001193125-26-115298.md) | [203](/filings/0001193125-26-240712.md) | [180](/filings/0001193125-26-366101.md) | [184](/filings/0001193125-25-294766.md) | [231](/filings/0001193125-26-366101.md) | [225](/filings/0001193125-26-240712.md) | [212](/filings/0001193125-26-366101.md) |
| Current assets | $m | [529](/filings/0000950170-25-054522.md) | [531](/filings/0000950170-25-054522.md) | [502](/filings/0000950170-25-078622.md) | [507](/filings/0001193125-25-190723.md) | [501](/filings/0001193125-25-294766.md) | [490](/filings/0001193125-26-115298.md) | [511](/filings/0001193125-26-240712.md) | [516](/filings/0001193125-26-366101.md) | [522](/filings/0001193125-25-294766.md) | [517](/filings/0001193125-26-366101.md) | [514](/filings/0001193125-26-240712.md) | [527](/filings/0001193125-26-366101.md) |
| Total assets | $m | [753](/filings/0000950170-25-054522.md) | [756](/filings/0000950170-25-054522.md) | [736](/filings/0000950170-25-078622.md) | [742](/filings/0001193125-25-190723.md) | [747](/filings/0001193125-25-294766.md) | [729](/filings/0001193125-26-115298.md) | [747](/filings/0001193125-26-240712.md) | [749](/filings/0001193125-26-366101.md) | [752](/filings/0001193125-25-294766.md) | [743](/filings/0001193125-26-366101.md) | [734](/filings/0001193125-26-240712.md) | [743](/filings/0001193125-26-366101.md) |
| Current liabilities | $m | [125](/filings/0000950170-25-054522.md) | [111](/filings/0000950170-25-054522.md) | [103](/filings/0000950170-25-078622.md) | [114](/filings/0001193125-25-190723.md) | [116](/filings/0001193125-25-294766.md) | [113](/filings/0001193125-26-115298.md) | [126](/filings/0001193125-26-240712.md) | [131](/filings/0001193125-26-366101.md) | [129](/filings/0001193125-25-294766.md) | [113](/filings/0001193125-26-366101.md) | [113](/filings/0001193125-26-240712.md) | [124](/filings/0001193125-26-366101.md) |
| Total liabilities | $m | [259](/filings/0000950170-25-054522.md) | [248](/filings/0000950170-25-054522.md) | [244](/filings/0000950170-25-078622.md) | [248](/filings/0001193125-25-190723.md) | [253](/filings/0001193125-25-294766.md) | [246](/filings/0001193125-26-115298.md) | [252](/filings/0001193125-26-240712.md) | [256](/filings/0001193125-26-366101.md) | [252](/filings/0001193125-25-294766.md) | [232](/filings/0001193125-26-366101.md) | [227](/filings/0001193125-26-240712.md) | [236](/filings/0001193125-26-366101.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [492](/filings/0000950170-25-054522.md) | [506](/filings/0000950170-25-054522.md) | [490](/filings/0000950170-25-078622.md) | [492](/filings/0001193125-25-190723.md) | [491](/filings/0001193125-25-294766.md) | [481](/filings/0001193125-26-115298.md) | [493](/filings/0001193125-26-240712.md) | [490](/filings/0001193125-26-366101.md) | [497](/filings/0001193125-25-294766.md) | [509](/filings/0001193125-26-366101.md) | [505](/filings/0001193125-26-240712.md) | [506](/filings/0001193125-26-366101.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.9) d](/filings/0000950170-25-054522.md) | [69.4 d](/filings/0001193125-26-115298.md) | [(18.1)](/filings/0000950170-25-078622.md) | [(17.8) d](/filings/0001193125-25-190723.md) | [(4.7) d](/filings/0001193125-25-294766.md) | [39.1 d](/filings/0001193125-26-115298.md) | [(7.2)](/filings/0001193125-26-240712.md) | [(3.8) d](/filings/0001193125-26-366101.md) | [12.3 d](/filings/0001193125-25-294766.md) | [56.7 d](/filings/0001193125-26-115298.md) | [7.0](/filings/0001193125-26-240712.md) | [(0.4) d](/filings/0001193125-26-366101.md) |
| Capital expenditure | $m | [2.0 d](/filings/0000950170-24-133544.md) | [1.6 d](/filings/0001193125-26-115298.md) | [1.6](/filings/0000950170-25-078622.md) | [2.3 d](/filings/0001193125-25-190723.md) | [2.5 d](/filings/0001193125-25-294766.md) | [1.6 d](/filings/0001193125-26-115298.md) | [1.5](/filings/0001193125-26-240712.md) | [1.3 d](/filings/0001193125-26-366101.md) | [0.7 d](/filings/0001193125-25-294766.md) | [1.0 d](/filings/0001193125-26-115298.md) | [1.2](/filings/0001193125-26-240712.md) | [1.2 d](/filings/0001193125-26-366101.md) |
| Dividends paid | $m | [7.7 d](/filings/0000950170-24-133544.md) | [7.7 d](/filings/0001193125-26-115298.md) | [7.8](/filings/0000950170-25-078622.md) | [7.8 d](/filings/0001193125-25-190723.md) | [7.8 d](/filings/0001193125-25-294766.md) | [7.8 d](/filings/0001193125-26-115298.md) | [0.0](/filings/0001193125-26-240712.md) | [15.6 d](/filings/0001193125-26-366101.md) | [7.7 d](/filings/0001193125-25-294766.md) | [7.7 d](/filings/0001193125-26-115298.md) | [7.7](/filings/0001193125-26-240712.md) | [8.9 d](/filings/0001193125-26-366101.md) |
| Share repurchases | $m | [1.9 d](/filings/0000950170-24-133544.md) | [0.8 d](/filings/0001193125-26-115298.md) | [1.1](/filings/0000950170-25-078622.md) | [0.0 d](/filings/0001193125-25-190723.md) | [1.5 d](/filings/0001193125-25-294766.md) | [0.0 d](/filings/0001193125-26-115298.md) | [0.0](/filings/0001193125-26-240712.md) | [1.6 d](/filings/0001193125-26-366101.md) | [0.0 d](/filings/0001193125-25-294766.md) | [2.3 d](/filings/0001193125-26-115298.md) | [1.5](/filings/0001193125-26-240712.md) | [0.0 d](/filings/0001193125-26-366101.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.7](/filings/0000950170-25-054522.md) | [22.6](/filings/0000950170-25-054522.md) | [22.7](/filings/0000950170-25-054522.md) | [22.7](/filings/0000950170-25-054522.md) | [22.7](/filings/0000950170-25-078622.md) | [22.7](/filings/0001193125-25-190723.md) | [22.6](/filings/0001193125-25-294766.md) | [22.5](/filings/0001193125-26-240712.md) | [22.6](/filings/0001193125-26-366101.md) | [22.7](/filings/0001193125-25-294766.md) | [22.8](/filings/0001193125-26-240712.md) | [23.1](/filings/0001193125-26-366101.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.